LAB
Standard Biotools Inc
0.7399$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.8% | +140.7% | -8.9% | -3.8% | -10.2% | -5.3% | -3.9% | -3.1% | +5.2% | +12.6% | -1.9% | |
| – | -7.3% | +246.1% | -12.3% | -5.5% | -17.1% | -8.5% | +47.1% | -6.6% | -3.8% | +14.8% | -0.9% | |
| – | -35.1% | +455.2% | -6.0% | -21.9% | -20.8% | -9.5% | +5.1% | -18.4% | -8.7% | +124.8% | +1.6% | |
| – | -10.8% | +302.4% | -14.6% | -7.2% | -20.1% | -11.9% | -8.1% | -17.8% | -3.8% | +142.7% | +4.7% | |
| – | +18.7% | +83.2% | -9.9% | +8.9% | -4.8% | +5.6% | -58.8% | -7.4% | -0.8% | +23.9% | -5.3% | |
| – | -6.4% | +96.6% | +5.6% | +0.1% | -4.5% | +3.4% | -42.6% | +5.2% | -21.4% | -6.9% | -8.0% | |
| – | – | – | – | – | -1.2% | -0.5% | -33.5% | -6.5% | +4.1% | – | – | |
| – | +0.1% | 0.0% | 0.0% | +0.1% | +4.7% | +0.4% | – | – | – | – | – | |
| – | -67.1% | +1,662.2% | -2.9% | -3.0% | +23.9% | -3.1% | – | – | – | – | – | |
| – | -66.1% | +25.3% | -0.9% | -3.2% | -26.8% | -11.1% | +5.9% | +5.7% | +2.5% | -45.6% | +11.9% | |
| – | +111.1% | +11.2% | +1.9% | -2.6% | -45.4% | -14.7% | +74.3% | +10.1% | +0.3% | -61.0% | +34.6% | |
| – | +611.1% | -5.3% | +0.2% | +0.7% | -89.8% | +1.7% | -19.6% | +0.4% | +7.4% | +0.9% | +1.5% | |
| – | +26.1% | +42.3% | -4.3% | -13.1% | +12.4% | -4.1% | -37.8% | -9.7% | -18.3% | +48.1% | +19.3% | |
| – | -93.3% | -92.5% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | +253.7% | -11.6% | -4.1% | -3.6% | -3.6% | -6.6% | -5.9% | +6.2% | +32.2% | -3.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | +268.9% | +26.6% | -0.2% | +0.8% | +1.0% | +0.6% | +0.6% | +0.6% | +0.8% | +0.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.